With a critical deadline looming that threatens to raise healthcare premiums for millions, House Republican leaders have introduced a comprehensive 111-page legislative package aimed at lowering costs through market-based reforms rather than expanded government subsidies. The draft bill is on a
A critical performance audit from the U.S. Government Accountability Office (GAO) has revealed that persistent and severe understaffing within the Food and Drug Administration (FDA) is critically undermining the agency's ability to oversee medical device recalls, leading to dangerous delays that
The persistent friction of prior authorization has long been a source of frustration within the American healthcare system, often creating significant delays in patient care and burying clinicians under a mountain of administrative tasks. While the prevailing narrative has frequently positioned
American health care policy has arrived at a critical crossroads, forcing a legislative showdown between two fundamentally different visions for its future that will shape access, cost, and control for millions. Lawmakers must now decide whether to once again extend the enhanced premium subsidies
A comprehensive analysis of the American public's views on health care reveals a profound national paradox: while a solid majority agrees that the federal government has a fundamental duty to ensure coverage for all citizens, this consensus shatters when it comes to the method of delivery. This
The year 2026 is poised to be a watershed moment for the substance use disorder (SUD) treatment industry, compelling providers to fundamentally redefine their value proposition amid unprecedented market and policy pressures. Following a tumultuous 2025 characterized by investor hesitation,
